MVP.AX · MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED
Australia · RS rating 42 · As of 2026-10-14
| Price | 0.40 AUD |
|---|---|
| 1-day change | +2.6% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 13 / 52 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 26 / 12 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +46.3% |
| Market cap (USD) | $32.5M |